00446nas a2200157   4500000000100000008004100001100001500042700001300057700001200070700001400082700001200096245013200108300001000240490000600250022003200256       2017                            d1 aK. Hagberg1 aH. Divan1 aS. Fang1 aJ. Nickel1 aS. Jick00aRisk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia  a83-910 v9  a1179-1349 (Print) 1179-1349